Global bioproduction leader 21st.BIO has announced that it will grant access to its precision fermentation technology platform to ingredient manufacturers, enabling the production of dairy proteins at competitive costs. This follows the successful scaling of the beta-lactoglobulin protein, a major protein in milk that provides valuable nutrition and textural components of milk and other dairy ingredients.
By making its precision fermentation technology platform widely available, 21st.BIO aims to mitigate the cost and time associated with development, making proven industrial-scale production technology for precision fermentation of alternative proteins accessible to ingredient manufacturers. This sustainable and less carbon and resource-intensive alternative to traditional animal-based production methods helps to stabilize global food supply chains.
According to recent studies, producing proteins via precision fermentation reduces greenhouse gas emissions, land, and water use by 90 to 96% compared to animal-derived production. Customers of 21st.BIO will have access to world-leading industrial production strains, fermentation processes, as well as support with scale-up, tech transfers to contract manufacturers, and regulatory approvals to get to market at speed and with lower costs. 21st.BIO continuously optimizes the strains and processes, ensuring customers are always ahead of the market.
21st.BIO’s technology can be optimized for each customer’s specific purpose, such as the nutritional fortification of a plant-based product, improvement of texture in alternative dairy, and medical nutrition. Customers of 21st.BIO can be innovative start-ups planning to take one or several proteins to the market, established players expanding into sustainable alternatives, and dairy companies aiming to grow with the increasing global demand for proteins while reducing their footprint on the environment. 21st.BIO’s technology base is already used to provide dozens of food-grade products on the market today. The technology foundation is licensed from Novozymes, who has 40 years’ experience perfecting production strains and processes for industrial production.
